Literature DB >> 22842860

Role of the EU Framework in Regulation of Stem Cell-Based Products.

Giovanni Migliaccio1, Cristina Pintus.   

Abstract

The use of stem cells for therapeutic purposes is regulated by two overlapping sets of rules. If used for transplantation, stem cells are covered by the collection, traceability and technical aspects of three European directives. When the stem cells are used as part of a medicinal product, they are covered by the legislation on pharmaceutical production and marketing authorization-in particular, by Regulation 1394/2007/EC.

Year:  2013        PMID: 22842860     DOI: 10.1007/10_2012_142

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  2 in total

1.  Regulation of cell-based therapies in Europe: current challenges and emerging issues.

Authors:  Alessandro Blasimme; Emmanuelle Rial-Sebbag
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

2.  Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use.

Authors:  Patricia Gálvez; Beatriz Clares; Maria Bermejo; Abdelkrim Hmadcha; Bernat Soria
Journal:  Stem Cells Dev       Date:  2014-02-20       Impact factor: 3.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.